
Semaglutide: A Comprehensive Review of Efficacy, Safety Concerns, and Future Directions in Metabolic Disease Management
Abstract Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), has rapidly gained prominence in the treatment of type 2 diabetes mellitus (T2DM) and obesity. Its potent effects on glycemic control and weight reduction have led […]